NCT00304447View on ClinicalTrials.gov

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

January 31, 2004

Conditions
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Interventions
DRUG

Mylotarg

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00304447 - Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia | Biotech Hunter | Biotech Hunter